These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
871 related items for PubMed ID: 15362527
1. [Prostate cancer after prostatectomy for benign prostatic hyperplasia]. Hua L, Zhang J, Wu H, Sui Y, Zhang W, Qian L, Wang Z. Zhonghua Nan Ke Xue; 2004 Aug; 10(8):612-3. PubMed ID: 15362527 [Abstract] [Full Text] [Related]
2. Postoperative PSA and PSA velocity identify presence of prostate cancer after various surgical interventions for benign prostatic hyperplasia. Helfand BT, Anderson CB, Fought A, Kim DY, Vyas A, McVary KT. Urology; 2009 Jul; 74(1):177-83. PubMed ID: 19428074 [Abstract] [Full Text] [Related]
3. [Clinic analysis of repeat prostatectomy after transurethral prostatectomy for benign prostatic hyperplasia]. Mao QZ, Rong S, Li HZ, Ji ZG, Xia M, Zang MF. Zhonghua Yi Xue Za Zhi; 2004 Mar 02; 84(5):372-4. PubMed ID: 15061986 [Abstract] [Full Text] [Related]
4. [Prostatic cancer developing after transurethral resection of the prostate for benign prostatic hyperplasia]. Tanaka Y, Aoyama H, Momose H, Ono T, Samma S, Tanaka N, Akiyama T, Tani Y, Masuda Y, Matsuki H, Tani M, Tanaka M. Hinyokika Kiyo; 2001 Jan 02; 47(1):11-4. PubMed ID: 11235214 [Abstract] [Full Text] [Related]
6. Percent free PSA as an additional measure in a prostate cancer screen. Miele ME. Clin Lab Sci; 2001 Jan 02; 14(2):102-7. PubMed ID: 15625982 [Abstract] [Full Text] [Related]
7. [Clinical study on prostatic cancer detected incidentally by transurethral resection of the prostate]. Hayakawa T, Mitsuya H, Kojima M, Hayase Y. Hinyokika Kiyo; 2002 Jan 02; 48(1):13-6. PubMed ID: 11868378 [Abstract] [Full Text] [Related]
8. Clinical relevance of transurethral resection of the prostate in "asymptomatic" patients with an elevated prostate-specific antigen level. van Renterghem K, Van Koeveringe G, Achten R, Van Kerrebroeck P. Eur Urol; 2007 Sep 02; 52(3):819-26. PubMed ID: 17418482 [Abstract] [Full Text] [Related]
11. The impact of systematic prostate biopsy on prostate cancer incidence in men with symptomatic benign prostatic hyperplasia undergoing transurethral resection of the prostate. Ornstein DK, Rao GS, Smith DS, Andriole GL. J Urol; 1997 Mar 02; 157(3):880-3; discussion 883-4. PubMed ID: 9072591 [Abstract] [Full Text] [Related]
12. [Clinical study of stage a prostatic cancer detected incidentally by transurethral resection of the prostate]. Nakanishi S, Gotou T, Sawada A, Shibasaki N, Ishitoya T, Okumura K. Hinyokika Kiyo; 2009 Jan 02; 55(1):5-8. PubMed ID: 19227204 [Abstract] [Full Text] [Related]
15. [Clinical relevance of incidental prostate carcinoma. A retrospective study]. Schürholz T, Schulze H, Finke W, Lange S, Senge T. Urologe A; 1996 Jul 02; 35(4):315-20. PubMed ID: 8928361 [Abstract] [Full Text] [Related]
16. [Diagnosis and treatment of incidental prostate cancer following TUPVP (a report of 15 cases)]. Gu X, Zhu Q, Zhang P, Zhang Y, Lu Z, Xu Y, Huang S. Zhonghua Nan Ke Xue; 2004 Nov 02; 10(11):849-50, 854. PubMed ID: 15595689 [Abstract] [Full Text] [Related]
18. Role of transurethral biopsy sampling of the prostate to diagnose prostate cancer in men undergoing surgical intervention for benign prostatic hyperplasia. Bales GT, Flynn TJ, Kynaston HG, Golash A, Hart A, Kim HL, Gerber GS. Tech Urol; 2000 Sep 02; 6(3):201-4. PubMed ID: 10963487 [Abstract] [Full Text] [Related]